Search This Blog

Monday, November 4, 2019

Iovance Biotherapeutics EPS misses by $0.01

Iovance Biotherapeutics (NASDAQ:IOVA): Q3 GAAP EPS of -$0.40 misses by $0.01.
Cash, cash equivalents, and short-term investments of $361.87M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)